Trade

with

Parexel International Corp
(NASDAQ: PRXL)
AdChoices
63.74
+0.24
+0.38%
After Hours :
63.74
0.00
0.00%

Open

64.01

Previous Close

63.50

Volume (Avg)

378.86k (556.95k)

Day's Range

63.15-64.02

52Wk Range

37.53-64.46

Market Cap.

3.49B

Dividend Rate ( Yield )

-

Beta

0.95

Shares Outstanding

54.73M

P/E Ratio (EPS)

28.41 (2.25)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 2.27B

    • Net Income

    • 129.09M

    • Market Cap.

    • 3.49B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 5.70

    • PEG (Price/Earnings Growth) Ratio

    • 1.36

    • Beta

    • 0.95

    • Forward P/E

    • 24.75

    • Price/Sales

    • 1.62

    • Price/Book Value

    • 6.04

    • Price/Cash flow

    • 12.74

      • EBITDA

      • 280.83M

      • Return on Capital %

      • 7.14

      • Return on Equity %

      • 23.12

      • Return on Assets %

      • 7.14

      • Book Value/Share

      • 10.55

      • Shares Outstanding

      • 54.73M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 60.67

        • Credit Rating

        • -

        • Analysts

        • 4

        • EPS Estimate

        • 2.57

        • Cashflow Estimate

        • 3.82

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 11.10

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • 34.50

          • -5.55

          • Net Income

            Q/Q (last year)

          • 33.40

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 12.69

          • 47.82

          • Net Income

            5-Year Annual Average

          • 26.80

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 29.13

            • 42.70

            • Pre-Tax Margin

            • 8.29

            • 11.63

            • Net Profit Margin

            • 5.70

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 28.70

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 5.70

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 4.20

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.58

              • 0.62

              • Current Ratio

              • 1.45

              • 1.23

              • Quick Ratio

              • 1.30

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 3.17

              • 2.16

              • Book Value/Share

              • 10.55

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 28.33

                • 33.22

                • P/E Ratio 5-Year High

                • 28.70

                • 325.07

                • P/E Ratio 5-Year Low

                • 5.24

                • 154.73

                • Price/Sales Ratio

                • 1.61

                • 2.34

                • Price/Book Value

                • 6.03

                • 3.04

                • Price/Cash Flow Ratio

                • 12.74

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 23.12

                    (14.00)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 7.14

                    (4.90)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 13.53

                    (10.00)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 8.30k

                  • 17.17k

                  • Inventory Turnover

                  • -

                  • 5.07

                  • Asset Turnover

                  • 1.25

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  199.50M
                  Operating Margin
                  8.80
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  12.74
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  46.78%

                  Mutual Fund Ownership

                  62.64%

                  Float

                  98.19%

                  5% / Insider Ownership

                  2.83%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Health Care Fund

                  •  

                    5,077,400

                  • 5.65

                  • 9.29

                  • Neuberger Berman Genesis Fund

                  •  

                    1,453,155

                  • -1.47

                  • 2.66

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    1,104,836

                  • 0.20

                  • 2.03

                  • Fidelity Advisor® New Insights Fund

                  •  

                    1,093,350

                  • 0.00

                  • 2.00

                  • Vanguard Small Cap Index

                  •  

                    950,660

                  • -4.10

                  • 1.74

                  • Vanguard Total Stock Mkt Idx

                  •  

                    920,494

                  • 0.16

                  • 1.68

                  • iShares Russell 2000 (AU)

                  •  

                    845,543

                  • -1.46

                  • 1.55

                  • Eagle Small Cap Growth Fund

                  •  

                    725,615

                  • 29.87

                  • 1.33

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    642,540

                  • -5.95

                  • 1.17

                  • Stratton Small Cap Value Fund

                  •  

                    622,850

                  • 0.00

                  • 1.14

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    5,871,308

                  • +1.09%

                  • 10.74

                  • Vanguard Group, Inc.

                  •  

                    4,182,807

                  • +0.50%

                  • 7.65

                  • BlackRock Fund Advisors

                  •  

                    3,091,110

                  • -5.85%

                  • 5.65

                  • Fisher Asset Management, LLC

                  •  

                    2,427,492

                  • -1.93%

                  • 4.44

                  • Acadian Asset Management LLC

                  •  

                    2,147,771

                  • +208.36%

                  • 3.92

                  • Neuberger Berman LLC

                  •  

                    1,815,422

                  • -14.43%

                  • 3.32

                  • Fidelity Management and Research Company

                  •  

                    1,737,790

                  • -12.40%

                  • 3.18

                  • Schroder Investment Management North America Inc.

                  •  

                    1,615,082

                  • +9.74%

                  • 2.95

                  • Geneva Capital Management Ltd.

                  •  

                    1,394,868

                  • -2.25%

                  • 2.55

                  • State Street Corp

                  •  

                    1,302,629

                  • -1.91%

                  • 2.38

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Aggressive Growth

                  Style

                  Small Growth

                  Parexel International Corp was incorporated in 1983. The Company provides clinical research, medical communications, consulting, commercialization and informatics and advanced technology services to the worldwide pharmaceutical, biot...moreechnology, and medical device industries. The Company has three reporting segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). CRS constitutes its core business and include all phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. CRS service offerings include clinical trials management, observational studies, patient/dise...morease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. PCMS provides technical expertise and advice in such areas as drug development, regulatory affairs, and good manufacturing practice (GMP) compliance consulting. In addition, PCMS provides a full spectrum of market development, product development, commercialization, and targeted communications services in support of product launch. PCMS consultants also identify alternatives and propose solutions to address clients’ product development, registration, and commercialization issues. Additionally, PCMS provides reimbursement and market access (RMA) services. Perceptive provides information technology solutions designed to improve clients’ product development processes. Perceptive’s portfolio of products and services includes ClinPhone RTSM, medical imaging services, CTMS, EDC, web-based portals, systems integration, and patient diary applications. These solutions are sold individually or in combination, as elements of an eClinical suite. It competes with other biopharmaceutical services companies and other clinical research organizations (CROs) that provide one or more of the services being offered by it. Some of the biopharmaceutical services companies, such as Quintiles Transnational Corporation, Covance Inc., Pharmaceutical Product Development Inc., inVentiv Health, INC Research, and Icon plc, offer services that compete directly with its services at many levels.lessless

                  Key People

                  Mr. Josef H. Von Rickenbach

                  Founder/CEO/Chairman of the Board/Director

                  Ingo Bank

                  CFO/Chief Accounting Officer/Senior VP

                  Dr. Ulf M. Schneider

                  Chief Administrative Officer/Managing Director, Geographical/Senior VP

                  Mr. James F. Winschel, Jr

                  Executive VP

                  Joseph Avellone

                  Executive VP

                  • Parexel International Corp

                  • 195 West Street

                  • Waltham, MA 02451

                  • USA.Map

                  • Phone: +1 781 487-9900

                  • Fax: +1 781 487-0525

                  • parexel.com

                  Incorporated

                  1983

                  Employees

                  15,560

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: